Article
lncRNA‑CCDC26, as a novel biomarker, predicts prognosis in acute myeloid leukemia
9 Jul 2019
Abstract excerpt
The aim of the present study was to examine the expression and clinical significance of long non‑coding RNA (lncRNA)‑CCDC26 in patients with acute myeloid leukemia (AML), and to investigate the potential functions of CCDC26. The Gene Expression Omnibus database and reverse transcription‑quantitative polymerase chain reaction analysis were used to detect the expression levels of CCDC26 in patients with AML and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
